Skeletal muscle-specific overexpression of SIRT1 does not enhance whole-body energy expenditure or insulin sensitivity in young mice
- 19 April 2013
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 56 (7) , 1629-1637
Abstract
The NAD+-dependent protein deacetylase sirtuin (SIRT)1 is thought to be a key regulator of skeletal muscle metabolism. However, its precise role in the regulation of insulin sensitivity is unclear. Accordingly, we sought to determine the effect of skeletal muscle-specific overexpression of SIRT1 on skeletal muscle insulin sensitivity and whole-body energy metabolism.Keywords
This publication has 35 references indexed in Scilit:
- Sirtuin 1 (SIRT1) Deacetylase Activity Is Not Required for Mitochondrial Biogenesis or Peroxisome Proliferator-activated Receptor-γ Coactivator-1α (PGC-1α) Deacetylation following Endurance ExerciseJournal of Biological Chemistry, 2011
- SIRT1 and p53, effect on cancer, senescence and beyondBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- Protein deacetylation by SIRT1: An emerging key post-translational modification in metabolic regulationPharmacological Research, 2010
- SIRT1 Deacetylase in POMC Neurons Is Required for Homeostatic Defenses against Diet-Induced ObesityCell Metabolism, 2010
- Interdependence of AMPK and SIRT1 for Metabolic Adaptation to Fasting and Exercise in Skeletal MuscleCell Metabolism, 2010
- AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activityNature, 2009
- Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cellsBiochemical and Biophysical Research Communications, 2009
- SirT1 Gain of Function Increases Energy Efficiency and Prevents Diabetes in MiceCell Metabolism, 2008
- Sirt1 protects against high-fat diet-induced metabolic damageProceedings of the National Academy of Sciences, 2008
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007